Press releases
- Exelixis to Present at the William Blair 44th Annual Growth Stock Conference
- Exelixis Announces Settlement of CABOMETYX® (cabozantinib) Patent Litigation with Cipla Limited and Cipla USA
- Exelixis to Webcast Fireside Chats as Part of Investor Conferences in May
- Exelixis Announces First Quarter 2024 Financial Results and Provides Corporate Update
- Exelixis to Release First Quarter 2024 Financial Results on Tuesday, April 30, 2024
More ▼
Key statistics
On Friday, Exelixis Inc (EX9:DUS) closed at 19.74, -10.52% below its 52-week high of 22.06, set on Apr 29, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 18.99 |
---|---|
High | 19.74 |
Low | 18.98 |
Bid | 19.88 |
Offer | 20.11 |
Previous close | 19.11 |
Average volume | 55.10 |
---|---|
Shares outstanding | 291.29m |
Free float | 285.01m |
P/E (TTM) | 33.54 |
Market cap | 6.32bn USD |
EPS (TTM) | 0.6466 USD |
Data delayed at least 15 minutes, as of May 31 2024 18:31 BST.
More ▼